SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-005789
Filing Date
2024-10-10
Accepted
2024-10-10 16:10:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 INHIBIKASE THERAPEUTICS, INC. p24-2958sc13g.htm SC 13G 63032
2 JOINT FILING AGREEMENT p24-2958exhibit99.htm EX-99.1 6088
  Complete submission text file 0000902664-24-005789.txt   70695
Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

IRS No.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Subject) CIK: 0001750149 (see all company filings)

IRS No.: 263407249 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92155 | Film No.: 241365306
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)